Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endo International PLC (NASDAQ:ENDP)

12.38
Delayed Data
As of Jul 21
 +0.06 / +0.49%
Today’s Change
9.70
Today|||52-Week Range
24.93
-24.83%
Year-to-Date
Nektar's NKTR-181 Positive in Human Abuse Potential Study
Jul 19 / Zacks.com - Paid Partner Content
BioDelivery-Purdue Pharma Ink Marketing Deal for Pain Drug
Jul 13 / Zacks.com - Paid Partner Content
3 Biotech Stocks on Readers' Minds
Jul 19 / TheStreet.com - Paid Partner Content
Mallinckrodt to Pay $35M for Controlled Substances Probe
Jul 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close12.32
Today’s open12.37
Day’s range12.21 - 12.46
Volume2,543,418
Average volume (3 months)6,484,957
Market cap$2.8B
Dividend yield--
Data as of 4:00pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)-96.37%
Earnings growth (this year)-24.96%
Earnings growth (next 5 years)-12.21%
Revenue growth (last year)+22.69%
P/E ratioNM
Price/Sales0.91
Price/Book1.02

Competitors

 Today’s
change
Today’s
% change
AGIOAgios Pharmaceutical...-0.06-0.10%
PBHPrestige Brands Hold...+0.13+0.25%
HCMHutchison China Medi...+0.02+0.09%
CBPOChina Biologic Produ...-1.49-1.43%
Data as of 4:02pm ET, 07/21/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)$0.72
Annual revenue (last year)$4.0B
Annual profit (last year)-$3.3B
Net profit margin-80.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul V. Campanelli
Chief Operating Officer &
Executive Vice President
Terrance J. Coughlin
Corporate headquarters
Dublin, Dublin

Forecasts